ホームMCPワークベンチSkills
ホームワークベンチ通知マイページ
llms.txt · MCPガイドプライバシーポリシー · 利用規約 · サポートv1.8.3
  1. ホーム
  2. /反応

1-Isocyanatoadamantane → 1-(Adamant-1-yl)-3-(7-[2-[4-(2,4-dioxothiazolidin-5-ylmethyl)phenoxymethyl]-1-methyl-1H-benzimidazol-6-yloxy]naphthalen-1-yl)urea

HRID 412357
印刷

反応式

HRID 412357 の反応式
[NH2:1][C:2]1[CH:3]=[CH:4][CH:5]=[C:6]2[C:11]=1[CH:10]=[C:9]([O:12][C:13]1[CH:14]=[CH:15][C:16]3[N:20]=[C:19]([CH2:21][O:22][C:23]4[CH:36]=[CH:35][C:26]([CH2:27][CH:28]5[S:32][C:31](=[O:33])[NH:30][C:29]5=[O:34])=[CH:25][CH:24]=4)[N:18]([CH3:37])[C:17]=3[CH:38]=1)[CH:8]=[CH:7]2.[C:39]12([N:49]=[C:50]=[O:51])[CH2:48][CH:43]3[CH2:44][CH:45]([CH2:47][CH:41]([CH2:42]3)[CH2:40]1)[CH2:46]2>CN(C)C=O>[C:39]12([NH:49][C:50]([NH:1][C:2]3[C:11]4[C:6](=[CH:7][CH:8]=[C:9]([O:12][C:13]5[CH:14]=[CH:15][C:16]6[N:20]=[C:19]([CH2:21][O:22][C:23]7[CH:24]=[CH:25][C:26]([CH2:27][CH:28]8[S:32][C:31](=[O:33])[NH:30][C:29]8=[O:34])=[CH:35][CH:36]=7)[N:18]([CH3:37])[C:17]=6[CH:38]=5)[CH:10]=4)[CH:5]=[CH:4][CH:3]=3)=[O:51])[CH2:48][CH:43]3[CH2:44][CH:45]([CH2:47][CH:41]([CH2:42]3)[CH2:40]1)[CH2:46]2
参加物実験手順後処理出典と根拠反応ノート

参加物

4

反応物 2

HCID 20599951-IsocyanatoadamantaneHCID 98327115-[4-[6-(8-aminonaphthalen-2-yloxy)-1-methyl-1H-benzimidazol-2-ylmethoxy]benzyl]thiazolidine-2,4-dione

生成物 1

HCID 185375981-(Adamant-1-yl)-3-(7-[2-[4-(2,4-dioxothiazolidin-5-ylmethyl)phenoxymethyl]-1-methyl-1H-benzimidazol-6-yloxy]naphthalen-1-yl)urea収率 67.3%

試薬・触媒・溶媒 1

HCID 6228Dimethylformamide溶媒

実験手順

To a solution of 5-[4-[6-(8-aminonaphthalen-2-yloxy)-1-methyl-1H-benzimidazol-2-ylmethoxy]benzyl]thiazolidine-2,4-dione (0.5 g) in anhydrous N,N-dimethylformamide (10 ml) was added 1-adamantyl isocyanate (0.18 g) and the mixture was stirred at room temperature for 5 days. The reaction mixture was concentrated. The residue was purified by preparative reverse phase high performance liquid chromatography using acetonitrile:water=50:50→60:40→70:30 as the eluant to afford the title compound (0.45 g, mp 250° C. (dec)).

後処理

  1. concentrationThe reaction mixture was concentrated
  2. customThe residue was purified by preparative reverse phase high performance liquid chromatography

出典と根拠

ORDレコード
ord-2ce4ac67b7434aaabd7e58cbb1a85ba7
出典データセット
uspto-grants-2003_05
DOI
10.6084/m9.figshare.5104873.v1
特許番号
US06562849B1

反応ノート

このページの内容参加物実験手順後処理出典と根拠反応ノート